An NRAS mutation in primary malignant melanoma of the lung: a case report
Abstract Background Primary malignant melanoma of the lung (PML) is extremely rare. No precursor lesions of PML have been identified, and little is known about the genetic mutations associated with the disease. Typically, 15-20% of malignant melanomas possess NRAS gene mutations, but no cases of NRA...
Saved in:
Main Authors: | Takashi Hibiya (Author), Meiro Tanaka (Author), Mai Matsumura (Author), Ayako Aoki (Author), Tadashi Ikegami (Author), Koji Okudela (Author), Naomi Kawano (Author), Kenichi Ohashi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uterine carcinosarcoma-induced pulmonary tumor thrombotic microangiopathy: A case report
by: Takashi Hibiya, et al.
Published: (2018) -
Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
by: Fanny Barel, et al.
Published: (2017) -
MEK inhibitors for the treatment of NRAS mutant melanoma
by: Sarkisian S, et al.
Published: (2018) -
BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
by: Ismail Yilmaz, et al.
Published: (2015) -
Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation
by: Renée J.H. Richters, et al.
Published: (2020)